Literature DB >> 12437272

A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.

Ruth Davies1, David Crabbe, Paul Roderick, Jonathan R Goddard, James Raftery, Praful Patel.   

Abstract

A discrete event simulation model has evaluated a screening programme for Helicobacter pylori infection (H. pylori) in which individuals under the age of 50 years would be screened once. Eradication of H. pylori would reduce the peptic ulcer risk immediately and the gastric cancer risk after a fixed delay. The data were derived from published databases and peer reviewed papers. The simulation model, using variance reduction techniques, predicted that a screening programme would reduce morbidity and deaths but could cost around 19 million pounds for England and Wales in the first year of screening. A factorial design analysis showed the sensitivity of key variables. An increase in the opportunistic testing was found significantly to reduce the impact of screening.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437272     DOI: 10.1023/a:1020326005465

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  13 in total

1.  Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland.

Authors:  L J Murray; E E McCrum; A E Evans; K B Bamford
Journal:  Int J Epidemiol       Date:  1997-08       Impact factor: 7.196

2.  Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.

Authors:  J H Kurata; A N Nogawa
Journal:  J Clin Gastroenterol       Date:  1997-01       Impact factor: 3.062

3.  Using age, period and cohort models to estimate future mortality rates.

Authors:  C Osmond
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

4.  The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors.

Authors:  M Woodward; C E Morrison; K E McColl
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

5.  Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group.

Authors:  R A Feldman; J J Deeks; S J Evans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

6.  H pylori and gastric cancer.

Authors:  D Forman; P Webb; J Parsonnet
Journal:  Lancet       Date:  1994-01-22       Impact factor: 79.321

7.  Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Authors:  T Lind; S Veldhuyzen van Zanten; P Unge; R Spiller; E Bayerdörffer; C O'Morain; K D Bardhan; M Bradette; N Chiba; M Wrangstadh; C Cederberg; J P Idström
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

8.  Prospective screening of dyspeptic patients by Helicobacter pylori serology.

Authors:  P Patel; S Khulusi; M A Mendall; R Lloyd; R Jazrawi; J D Maxwell; T C Northfield
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

9.  Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.

Authors:  J Parsonnet; R A Harris; H M Hack; D K Owens
Journal:  Lancet       Date:  1996-07-20       Impact factor: 79.321

10.  Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group.

Authors: 
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

View more
  10 in total

Review 1.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 2.  Length of stay-based patient flow models: recent developments and future directions.

Authors:  Adele Marshall; Christos Vasilakis; Elia El-Darzi
Journal:  Health Care Manag Sci       Date:  2005-08

3.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

4.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

5.  Keeping the noise down: common random numbers for disease simulation modeling.

Authors:  Natasha K Stout; Sue J Goldie
Journal:  Health Care Manag Sci       Date:  2008-12

6.  Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity.

Authors:  Elliot Lee; Mariel S Lavieri; Michael L Volk; Yongcai Xu
Journal:  Health Care Manag Sci       Date:  2014-10-12

Review 7.  Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.

Authors:  Iris Lansdorp-Vogelaar; Linda Sharp
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-09-27       Impact factor: 3.043

8.  Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.

Authors:  A Kowada
Journal:  Epidemiol Infect       Date:  2018-07-30       Impact factor: 4.434

9.  Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence.

Authors:  Susan H Boklage; Allen W Mangel; Varun Ramamohan; Deirdre Mladsi; Tao Wang
Journal:  Patient Prefer Adherence       Date:  2016-06-08       Impact factor: 2.711

10.  Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States.

Authors:  Susan H Boklage; Allen W Mangel; Varun Ramamohan; Deirdre Mladsi; Tao Wang
Journal:  Patient Prefer Adherence       Date:  2016-01-21       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.